Spectral AI, Inc. (MDAI)
| Market Cap | 60.15M +98.0% |
| Revenue (ttm) | 19.65M -33.6% |
| Net Income | -7.57M |
| EPS | -0.29 |
| Shares Out | 31.82M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 292,598 |
| Open | 1.930 |
| Previous Close | 1.910 |
| Day's Range | 1.830 - 1.970 |
| 52-Week Range | 1.130 - 3.210 |
| Beta | 0.91 |
| Analysts | Strong Buy |
| Price Target | 3.00 (+58.73%) |
| Earnings Date | May 12, 2026 |
About MDAI
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and ... [Read more]
Financial Performance
In 2025, Spectral AI's revenue was $19.65 million, a decrease of -33.57% compared to the previous year's $29.58 million. Losses were -$7.57 million, -50.05% less than in 2024.
Financial StatementsAnalyst Summary
According to one analyst, the rating for MDAI stock is "Strong Buy" and the 12-month stock price target is $3.0.
News
Spectral AI to Feature DeepView® System at 2026 American Burn Association Annual Meeting
DALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Names David McGuire, CPA, as Chief Financial Officer
DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026
Overview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 Million Cash Rose to $15.4 Million at December 31, 2025 DALLAS, March 24, 2026 (GLOBE NEWSWIRE) -- Spectral ...
Spectral AI Stock Jumps After $31.7 Million Funding Award
Spectral AI Inc (NASDAQ:MDAI) stock is trading higher Thursday morning after the medical diagnostics company said it received $31.7 million in new funding from the Biomedical Advanced Research and Dev...
Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System
DALLAS, March 18, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Schedules 2025 Fourth Quarter and Full Year Financial Results and Conference Call
DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Names Vincent S. Capone as Chief Executive Officer
DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026
DALLAS, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
DeepView™ System Featured at 2025 US Burn Conferences
DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI Announces 2025 Third Quarter Financial Results
Q3 Overview Research & Development Revenue of $3.8 Million; $15.6 Million in YTD Revenue for 2025 Strong Cash position of $10.5 Million and progress toward FDA De Novo submission DALLAS, Nov. 11, 2025...
Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call
DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI raises $7.6 Million of Additional Growth Capital
DALLAS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI Named to TIME's List of World's Top HealthTech Companies 2025
DALLAS, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
DeepView® System highlighted at the European Burns Association Congress
DALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Announces 2025 Second Quarter Financial Results
Q2 Overview Research & Development Revenue of $5.1 Million, total revenue for the first half of 2025 of $11.8 Million Strong Cash position of $10.5 Million Submission of De Novo application to FDA com...
Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call
DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System and focused on medical diagnostics for faster and mor...
Spectral AI Announces Submission to FDA of its DeepView® System
DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...
DeepView® System highlighted at the annual British Burn Association conference
DALLAS, June 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer
DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more a...
Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders
DALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more a...
Spectral AI Announces 2025 First Quarter Financial Results
Q1 Overview Research & Development Revenue of $6.7 Million Improved Capital Structure Reflected in Cash of $14.1 Million Continued work on planned De Novo submission to the FDA in the first half of 20...
Burn clinicians present positive findings of the DeepView® System's accuracy at the American Burn Association annual meeting
DALLAS, April 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging a...
Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results
2024 Research & Development Revenue of $30 Million
Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization
DALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging a...
Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP
DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from...